Literature DB >> 23274665

Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States.

Maria Sjölund Karlsson, Anna Bowen, Roshan Reporter, Jason P Folster, Julian E Grass, Rebecca L Howie, Julia Taylor, Jean M Whichard.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23274665      PMCID: PMC3591876          DOI: 10.1128/AAC.02360-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  9 in total

1.  Practice guidelines for the management of infectious diarrhea.

Authors:  R L Guerrant; T Van Gilder; T S Steiner; N M Thielman; L Slutsker; R V Tauxe; T Hennessy; P M Griffin; H DuPont; R B Sack; P Tarr; M Neill; I Nachamkin; L B Reller; M T Osterholm; M L Bennish; L K Pickering
Journal:  Clin Infect Dis       Date:  2001-01-30       Impact factor: 9.079

2.  Randomized comparison of azithromycin versus cefixime for treatment of shigellosis in children.

Authors:  Wilma Basualdo; Antonio Arbo
Journal:  Pediatr Infect Dis J       Date:  2003-04       Impact factor: 2.129

3.  Reduced azithromycin susceptibility in Shigella sonnei, United States.

Authors:  Rebecca Leigh Howie; Jason P Folster; Anna Bowen; Ezra J Barzilay; Jean M Whichard
Journal:  Microb Drug Resist       Date:  2010-07-12       Impact factor: 3.431

Review 4.  Antibiotic therapy for Shigella dysentery.

Authors:  Prince Rh Christopher; Kirubah V David; Sushil M John; Venkatesan Sankarapandian
Journal:  Cochrane Database Syst Rev       Date:  2010-08-04

5.  Identification of plasmids by PCR-based replicon typing.

Authors:  Alessandra Carattoli; Alessia Bertini; Laura Villa; Vincenzo Falbo; Katie L Hopkins; E John Threlfall
Journal:  J Microbiol Methods       Date:  2005-06-02       Impact factor: 2.363

6.  Transmission risk factors and treatment of pediatric shigellosis during a large daycare center-associated outbreak of multidrug resistant Shigella sonnei: implications for the management of shigellosis outbreaks among children.

Authors:  Wences Arvelo; C Jon Hinkle; Thai An Nguyen; Thomas Weiser; Nichole Steinmuller; Fazle Khan; Steve Gladbach; Michele Parsons; Desmond Jennings; Bao Ping Zhu; Eric Mintz; Anna Bowen
Journal:  Pediatr Infect Dis J       Date:  2009-11       Impact factor: 2.129

7.  Antimicrobial susceptibility patterns of Shigella isolates in Foodborne Diseases Active Surveillance Network (FoodNet) sites, 2000-2010.

Authors:  Beletshachew Shiferaw; Suzanne Solghan; Amanda Palmer; Kevin Joyce; Ezra J Barzilay; Amy Krueger; Paul Cieslak
Journal:  Clin Infect Dis       Date:  2012-06       Impact factor: 9.079

8.  Foodborne illness acquired in the United States--major pathogens.

Authors:  Elaine Scallan; Robert M Hoekstra; Frederick J Angulo; Robert V Tauxe; Marc-Alain Widdowson; Sharon L Roy; Jeffery L Jones; Patricia M Griffin
Journal:  Emerg Infect Dis       Date:  2011-01       Impact factor: 6.883

9.  Macrolide-resistant Shigella sonnei.

Authors:  Leyla Boumghar-Bourtchai; Patricia Mariani-Kurkdjian; Edouard Bingen; Ingrid Filliol; Anne Dhalluin; Shadia Ait Ifrane; François-Xavier Weill; Roland Leclercq
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

  9 in total
  23 in total

1.  Virulence factors and mechanisms of antimicrobial resistance in Shigella strains from periurban areas of Lima (Peru).

Authors:  Angela Lluque; Susan Mosquito; Cláudia Gomes; Maribel Riveros; David Durand; Drake H Tilley; María Bernal; Ana Prada; Theresa J Ochoa; Joaquim Ruiz
Journal:  Int J Med Microbiol       Date:  2015-05-04       Impact factor: 3.473

2.  Case of Shigella flexneri infection with treatment failure due to azithromycin resistance in an HIV-positive patient.

Authors:  R-J Hassing; D C Melles; W H F Goessens; B J A Rijnders
Journal:  Infection       Date:  2014-02-02       Impact factor: 3.553

3.  In Vitro Resistance Selection in Shigella flexneri by Azithromycin, Ceftriaxone, Ciprofloxacin, Levofloxacin, and Moxifloxacin.

Authors:  George P Allen; Kayla A Harris
Journal:  Antimicrob Agents Chemother       Date:  2017-06-27       Impact factor: 5.191

4.  Shigellosis Outbreak in Al Batinah South Governorate, Oman: Case-control study.

Authors:  Idris Abaidani; Prasanna A Raju; Issa Al-Shualli; Khalid Al-Sa'di; Nasser Al-Shaqsi; Amer Al-Khatri
Journal:  Sultan Qaboos Univ Med J       Date:  2015-08-24

5.  Shigellosis in Subjects with Traveler's Diarrhea Versus Domestically Acquired Diarrhea: Implications for Antimicrobial Therapy and Human Immunodeficiency Virus Surveillance.

Authors:  Carlos Toro; Ana Arroyo; Ana Sarria; Nuria Iglesias; Ana Enríquez; Margarita Baquero; Concepción Ladrón de Guevara
Journal:  Am J Trop Med Hyg       Date:  2015-07-20       Impact factor: 2.345

Review 6.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

7.  Evaluation of Shigella Species Azithromycin CLSI Epidemiological Cutoff Values and Macrolide Resistance Genes.

Authors:  Muna Salah; Issa Shtayeh; Raed Ghneim; Randa Al-Qass; Ali Sabateen; Hiyam Marzouqa; Musa Hindiyeh
Journal:  J Clin Microbiol       Date:  2019-03-28       Impact factor: 5.948

8.  ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults.

Authors:  Mark S Riddle; Herbert L DuPont; Bradley A Connor
Journal:  Am J Gastroenterol       Date:  2016-04-12       Impact factor: 10.864

9.  Microbial sequencing analyses suggest the presence of a fecal veneer on indoor climbing wall holds.

Authors:  S L Bräuer; D Vuono; M J Carmichael; C Pepe-Ranney; A Strom; E Rabinowitz; D H Buckley; S H Zinder
Journal:  Curr Microbiol       Date:  2014-06-28       Impact factor: 2.188

Review 10.  Mechanism of action, resistance, synergism, and clinical implications of azithromycin.

Authors:  Mohsen Heidary; Ahmad Ebrahimi Samangani; Abolfazl Kargari; Aliakbar Kiani Nejad; Ilya Yashmi; Moloudsadat Motahar; Elahe Taki; Saeed Khoshnood
Journal:  J Clin Lab Anal       Date:  2022-04-21       Impact factor: 3.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.